Medicare is the U.S. federal health insurance program for adults age 65 and older, and for some younger people with qualifying disabilities.
Many Medicare beneficiaries ask whether the program will pay for Wegovy, a prescription weight‑loss medication that has become widely known for helping people lose weight and improve health.
Medicare’s coverage rules for prescription drugs are strictly defined by federal law and by how the drug is used medically.
The answer depends on the reason the medicine is prescribed and the type of Medicare coverage you have.
Calculate Your 2026 COLA Increase →Wegovy and What Is It Used For
Wegovy is the brand name for the drug semaglutide. Doctors prescribe Wegovy to help adults with obesity or overweight to lose weight when used with diet and exercise. It belongs to a class of medicines called glucagon‑like peptide‑1 (GLP‑1) receptor agonists.
Wegovy is available as an injection given once per week or as an oral tablet taken daily.
In 2024, the U.S. Food and Drug Administration (FDA) also approved Wegovy for reducing the risk of serious heart problems, including heart attack and stroke, in adults who are overweight or have obesity and who have established cardiovascular disease.
This FDA‑approved cardiovascular use is an important distinction for Medicare coverage.
Does Medicare Cover Wegovy for Weight Loss?
No. Medicare generally does not pay for Wegovy when it is prescribed only for weight loss or weight management. Federal law specifically excludes drugs prescribed solely for weight loss from coverage under Medicare Part D prescription drug plans.
This rule was established when Congress created the Part D benefit, and it still applies today.
Because Wegovy is often prescribed for weight loss, most Medicare beneficiaries cannot expect their Part D plan to cover the drug when it is written for that purpose.
This means you will likely pay the full cost out of pocket unless the drug is being used for another medically accepted treatment.
When Can Medicare Cover Wegovy?
Medicare can cover Wegovy under Part D if the drug is prescribed for FDA‑approved medical uses that are not excluded by federal law. One such use is to reduce the risk of serious cardiovascular events in adults with existing heart disease who are overweight or have obesity.
When a doctor prescribes Wegovy for this purpose and the patient meets clinical criteria, Medicare Part D plans may include the drug on their formularies and pay part of the cost under the plan’s benefit design.
Original Medicare Parts A (hospital insurance) and Part B (medical insurance) do not cover most self‑administered drugs like Wegovy.
Coverage decisions for self‑administered drugs belong to Medicare Part D prescription drug plans and Medicare Advantage plans that include Part D benefits.
What Prescription Drug Plans and Coverage Rules Matter?
Medicare Part D plans are offered by private insurance companies approved by Medicare. Each plan maintains a formulary, a list of drugs the plan covers and the rules for coverage.
Plans vary widely in terms of which drugs they include, what prior authorizations they require, and how much beneficiaries must pay in copayments or coinsurance.
If Wegovy is not on your plan’s formulary, and you believe you qualify medically for coverage under the cardiovascular indication, you can ask the plan to make an exception. Plans must follow specific Medicare rules for exceptions and appeals.
Are There Pending Changes for 2026 and Beyond?
Yes. The federal government is testing new programs that could expand access to GLP‑1 drugs like Wegovy for weight management under certain terms.
One example is the Medicare GLP‑1 Bridge Demonstration, a short‑term program starting July 2026 that allows eligible Medicare beneficiaries to access select GLP‑1 medicines for weight loss outside of standard Part D coverage. This demonstration is separate from how drug coverage normally works in Part D.
The federal government is also developing the BALANCE Model, which aims to increase access to GLP‑1 medications in Medicare Part D beginning in January 2027. BALANCE is voluntary for drug manufacturers and plans and includes negotiations to lower drug costs and expand coverage terms for beneficiaries.
What You Should Know About Costs
If Wegovy is covered under Medicare Part D for an FDA‑approved medical use other than weight loss, you will still pay certain costs. These may include premiums, deductibles, copayments, or coinsurance based on your plan’s benefit design.
Plans are required to apply Medicare’s cost‑sharing rules and explain these costs to you.
If Wegovy is not covered under your plan for the treatment you need, you will generally pay the full price of the drug, which can be expensive without plan assistance.
Some patients explore manufacturer programs or other savings options, but Medicare law cannot cover weight‑loss use in standard Part D.
Does Original Medicare Cover Wegovy?
Original Medicare (Parts A and B) does not cover Wegovy because it is a self‑administered medication.
Only Part D plans provide coverage for self‑administered prescription drugs.
Can Medicare Advantage Plans Cover Wegovy?
Yes. Many Medicare Advantage plans include Part D drug coverage.
These plans often follow the same coverage rules as Part D stand‑alone plans and may cover Wegovy when it is prescribed for approved medical reasons like cardiovascular risk reduction. Coverage can vary by plan.
Is Medicare Going to Cover Wegovy for Weight Loss in 2026?
Medicare does not currently cover Wegovy for weight loss alone in 2026.
However, beneficiaries may see new access through the Medicare GLP‑1 Bridge Demonstration starting July 2026 and broader access under the BALANCE Model in 2027, if plans and manufacturers choose to participate.
Can I Appeal a Denial of Coverage?
Yes. If your Medicare drug plan denies coverage for Wegovy, you can request a formulary exception or file an appeal through Medicare’s formal appeals process. The plan must review the request and provide information on your rights to appeal.
For the most accurate and personalized details, you can visit the official Medicare plan finder at Medicare.gov or consult with your plan administrator and healthcare provider.
